FDA's agenda in limbo as Biden's nominee stalls in Senate :

President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate. It's an unexpected setback that could delay long-awaited decisions on everything from electronic cigarettes to prescription opioids. Biden nominated Dr. Robert Califf for the job in November after months of vetting candidates. Califf was viewed as a safe choice because he'd previously headed the FDA under President Barack Obama and had cleared the Senate by an overwhelming vote. But Califf's latest bid has been embroiled in disparate political controversies that threaten to sink his nomination and leave the FDA in limbo for months.

Related Keywords

Maine , United States , New Hampshire , North Carolina , Washington , White House , District Of Columbia , New Mexico , Capitol Hill , West Virginia , Susan Collins , Maggie Hassan , Diana Zuckerman , Elizabeth Warren , Joe Biden , Zeke Miller , Robert Califf , Xavier Becerra , Joe Manchin , Richard Burr , Stephen Ostroff , Janet Woodcock , Barack Obama , Ben Ray Luj , Susanb Anthony , Steven Grossman , National Center , Human Services , Drug Administration , Associated Press , Science Department , Senate Democrats , Republicans In Congress , Health Research , President Joe Biden , President Barack Obama , Human Services Secretary Xavier Becerra , Matthew Perrone , Associated Press Health , Howard Hughes Medical Institute ,